Stroke Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Stroke Management Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

The global stroke management market reached a value of US$ 31.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 46.8 Billion by 2027, exhibiting a CAGR of 6.97% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

A stroke occurs when a blockage or bleeding in blood vessels prevents an adequate supply of oxygen and nutrients to the brain. Its effective management assists in reducing brain damage and other complications. Stroke management involves a complete initial evaluation and assessment of patients with acute stroke using an echocardiogram, carotid ultrasound, cerebral angiogram, blood tests, computerized tomography (CT) scan, and magnetic resonance imaging (MRI). As per the evaluation and assessment results and patient's condition, treatment options for stroke like intravenous (IV) medication, endovascular procedures, intubation, and surgeries are opted by physicians.

Stroke Management Market Trends:
Chronic diseases, including hypertension, migraine, diabetes, dyslipidemia, obesity, cardiac diseases, atrial fibrillation, sickle cell, atrial fibrillation, carotid stenosis, and obstructive sleep apnea, are among the leading factors elevating the risk of stroke. This, in confluence with the increasing prevalence of these diseases among a significant part of the population, represents one of the primary factors escalating the need for stroke management across the globe. Additionally, physical inactivity, tobacco use, unhealthy diet and nutrition, and excessive drug and alcohol consumption are other factors influencing the market positively. Apart from this, due to the increasing geriatric population, which is more vulnerable to stroke, there is a rise in the demand for efficient stroke management. Furthermore, governing bodies of numerous countries are launching public health programs that encourage people to have periodic screening examinations for detecting chronic diseases. This, in confluence with the rising awareness among individuals about the advantages of early diagnosis and treatment, is leading to market growth. The approval of new and advanced devices and drugs is also creating a favorable outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global stroke management market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Diagnostics
Computed Tomography Scan (CT Scan)
Magnetic Resonance Imaging (MRI)
Carotid Ultrasound
Cerebral Angiography
Electrocardiography
Echocardiography
Others
Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive

Breakup by Application:

Ischemic Stroke
Haemorrhagic Stroke
Others

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Cardinal Health, General Electric Company, GlaxoSmithKline plc, Medtronic plc, Merck & Co. Inc. and Siemens Healthineers AG (Siemens AG).

Key Questions Answered in This Report:
How has the global stroke management market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global stroke management market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global stroke management market and who are the key players?
What is the degree of competition in the industry?